Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Simoens, Steven" or (type any "bookEditor issueEditor" and editor="Simoens, Steven")

Add to list
A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium

Masja Schmidt, Amber Werbrouck (UGent) , Nick Verhaeghe (UGent) , Elke De Wachter, Steven Simoens, Lieven Annemans (UGent) and Koen Putman

(2020) ACTA CLINICA BELGICA. 75(3). p.212-220
Add to list
Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetes

Amber Werbrouck (UGent) , Masja Schmidt, Koen Putman, Lieven Annemans (UGent) , Katrien Benhalima, Steven Simoens and Nick Verhaeghe (UGent)

(2020) EUROPEAN JOURNAL OF PUBLIC HEALTH. 30(3). p.396-401
Add to list
A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes : exploring uncharted territory

Amber Werbrouck (UGent) , Masja Schmidt, Koen Putman, Katrien Benhalima, Nick Verhaeghe (UGent) , Lieven Annemans (UGent) and Steven Simoens

(2019) DIABETES RESEARCH AND CLINICAL PRACTICE. 147. p.138-148
Add to list
Cost-effectiveness of oral care in institutionalized older people

Amber Werbrouck (UGent) , Masja Schmidt, Lieven Annemans (UGent) , Joke Duyck, Barbara Janssens (UGent) , Steven Simoens, Nick Verhaeghe (UGent) and Koen Putman

(2019) VALUE IN HEALTH. In Value in Health 22(Supplement 3). p.S631-S631
Add to list
- Conference Paper
- C3
- open access
What is already known about costs and cost-effectiveness of prevention of type 2 diabetes in women with gestational diabetes?

Amber Werbrouck (UGent) , Masja Schmidt, Koen Putman, Nick Verhaeghe (UGent) , Lieven Annemans (UGent) and Steven Simoens

(2018) Health Economics, 12th European conference, Abstracts.
Add to list
Strategies for newborn screening for cystic fibrosis : a systematic review of health economic evaluations

Masja Schmidt, Amber Werbrouck (UGent) , Nick Verhaeghe (UGent) , Elke De Wachter, Steven Simoens, Lieven Annemans (UGent) and Koen Putman

(2018) JOURNAL OF CYSTIC FIBROSIS. 17(3). p.306-315
Add to list
- Journal Article
- A1
- open access
Policies for biosimilar uptake in Europe : an overview

Evelien Moorkens, Arnold G Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Simon Keuerleber, Barbara Claus (UGent) , Maria Dimitrova, Guenka Petrova, Ljiljana Sović-Brkičić, et al.

(2017) PLOS ONE. 12(12).
Add to list
- Conference Paper
- C3
Budget impact analysis of the introduction of biosimilars in a Belgian tertiary care hospital : a simulation

Barbara Claus (UGent) , Steven Simoens, Sofie Vanhorebeek and Sabrina Commeyne

(2016) VALUE IN HEALTH. 19(7). p.A460-A460
Add to list
Chemotherapy drug shortages in paediatric oncology : a 14-year single-centre experience in Belgium

Tieneke Bauters (UGent) , Barbara Claus (UGent) , Koen Norga, Isabelle Huys, Steven Simoens and Genevieve Laureys (UGent)

(2016) JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 22(6). p.766-770
Add to list
Hurdles that impede economic evaluations of welfare interventions

Janne Schepers (UGent) , Lieven Annemans (UGent) and Steven Simoens

(2015) EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 15(4). p.635-642

Academic Bibliography

A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium

Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetes

A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes : exploring uncharted territory

Cost-effectiveness of oral care in institutionalized older people

What is already known about costs and cost-effectiveness of prevention of type 2 diabetes in women with gestational diabetes?

Strategies for newborn screening for cystic fibrosis : a systematic review of health economic evaluations

Policies for biosimilar uptake in Europe : an overview

Budget impact analysis of the introduction of biosimilars in a Belgian tertiary care hospital : a simulation

Chemotherapy drug shortages in paediatric oncology : a 14-year single-centre experience in Belgium

Hurdles that impede economic evaluations of welfare interventions

Contents

Support

Contact